CORT Corcept Therapeutics Incorporated
CORT Corcept Therapeutics Incorporated
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-23 1 neutral converging
POC $34.77 · VWAP $65.46 · +31.2% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $12.3M sold last open-market sell MAHONEY DAVID L
Cluster Director, Officer + 3 others sold $7.6M, Aug 5–18
Coverage
1 watchlist
CORT Price Structure
Loading timeframes…
Peers
Every watchlist CORT belongs to, members best 30-day change first — CORT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-06-30: revenue $256M, diluted EPS $0.36, net income $43M (SEC filing). Across the print the stock moved +23.2% (close before → first close after).
full note →Against street estimates
How CORT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
CORT research tape
92 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.